Potential Biomarkers for Predicting Congenital Cytomegalovirus Infection

Existing Reviews

Please note, new claims can take a short while to show up.

No claims yet.

Annotation Summary

Term Occurence Count Dictionary
ganciclovir 3 infectiousdiseasesdrugs
valacyclovir 1 infectiousdiseasesdrugs

There are not enough annotations found in this document to create the proximity graph.

Review

Having read the paper, please pick a pair of statements from the paper to indicate that a drug and disease are related.

Select Drug Character Offset Drug Term Instance
ganciclovir 25650 CMV infection. Twelve of the 16 infants with symptomatic congenital CMV infection received oral val ganciclovir (16–32 mg/kg/day) for six weeks. In the 16 infants who received antiviral treatments, four infants
ganciclovir 29272 with symptomatic congenital CMV infection, neonatal therapies, e.g., intravenous administration of ganciclovir [[4]] or oral administration of valganciclovir [[5]], might be considered.11. ConclusionsRecently, it
ganciclovir 29319 neonatal therapies, e.g., intravenous administration of ganciclovir [[4]] or oral administration of val ganciclovir [[5]], might be considered.11. ConclusionsRecently, it has been reported that the pentameric complex,
valacyclovir 27846 maternal blood [[51]], into the fetal peritoneal cavity [[52]], or oral administration of high-dosage valacyclovir to mothers [[53]], etc., might be considered for fetuses diagnosed with symptomatic congenital CMV infection
Select Disease Character Offset Disease Term Instance

You must be authorized to submit a review.